Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome

NCT02981888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-04-29

No results posted yet for this study

Summary

The purpose of this study is to find out the relationship between the bile acids, fatty acids (fatty acids are part of the diet) and bacteria that are present in the intestines.

Conditions

  • IBS

Interventions

RADIATION

X-Ray

X-ray of the abdomen will be performed to assess colonic transit

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Andrea Shin, MD · Indiana University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2023-04-27
Completion
2023-04-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02981888 on ClinicalTrials.gov